Quarterly report pursuant to Section 13 or 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.20.2
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis $ 755,487 $ 755,487
Gross Unrealized Gains 1,033,227 1,005,825
Value 1,788,714 1,761,312
Common Stock    
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis 755,487 755,487
Gross Unrealized Gains 1,033,227 1,005,825
Value $ 1,788,714 $ 1,761,312